Provided by Tiger Fintech (Singapore) Pte. Ltd.

Obalon Therapeutics Inc

3.05
+0.0000
Volume:- -
Turnover:- -
Market Cap:10.19M
PE:-0.74
High:3.05
Open:3.05
Low:3.05
Close:3.05
Loading ...
Mar 12, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 22, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 18, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 23, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 25, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 22, 2020

Major Issues Report

8-K - Current report